CN1261126C - Medicine for treating bone and joint tuberculosis - Google Patents
Medicine for treating bone and joint tuberculosis Download PDFInfo
- Publication number
- CN1261126C CN1261126C CNB200410072295XA CN200410072295A CN1261126C CN 1261126 C CN1261126 C CN 1261126C CN B200410072295X A CNB200410072295X A CN B200410072295XA CN 200410072295 A CN200410072295 A CN 200410072295A CN 1261126 C CN1261126 C CN 1261126C
- Authority
- CN
- China
- Prior art keywords
- parts
- treatment
- medicament
- portions
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides a medicament for treating bone and joint tuberculosis. The medicament is prepared from raw materials of traditional Chinese medicines according the following proportion: pangolin, turtle shell, silkworm larvae, scorpion, frankincense, myrrh, dahurian angelica root, notoginseng, sea horse, centipede, eupolyphaga, cockroach, rhizoma picrorhizae, honeysuckle, forsythia, rhubarb, fewflower lysionotus herb, mitten crab carapace, cynachum knomarovii and psoralea fruit. The medicament has the advantages: 1. the medicament has the advantages of no need of surgery or hospitalization, short course of treatment, low cost and no generation of drug resistance or drug tolerance especially for patients who are not healed by adopting chemotherapy for a long time; though drug resistance and drug tolerance exist in vivo, the therapeutic effect on taking the medicament is very ideal; the total excellence rate in clinics reaches 100%; and the cure rate reaches more than 95%; 2. the medicament also has the advantages of short course of treatment and good curative effect; each course of treatment is twenty days, and common patients can recover for 1 to 3 courses of treatment; 3. compared with chemicals, the medicament has the significant advantages of no damage to the liver and the action for protecting and nourishing the liver.
Description
Technical field
What the present invention relates to is the treatment tuberculosis, particularly be the medicine of treatment bone and joint tuberculosis.
Background technology
Existing treatment tuberculosis generally adopts the pharmacotherapy of Western medicine or Chinese medicine to treat, and in the described pharmacotherapy, the Western medicine toxic and side effects is big, and human body easily develops immunity to drugs, and pathogenic bacteria easily produces drug resistance.Existing long medicine time with the treatment by Chinese herbs method, curative effect is not obvious.Particularly adopt the effect of treatment by Chinese herbs more undesirable for bone and joint tuberculosis.
Summary of the invention
The objective of the invention is to overcome the deficiency of existing Chinese medicine Drug therapy bone and joint tuberculosis, provide a kind of toxic and side effects little, medicine time is short, the treatment bone that curative effect is good and the medicine of joint tuberculosis.
The present invention addresses the above problem the technical scheme that is adopted:
A kind of medicine for the treatment of bone and joint tuberculosis, wherein make raw materials of effective components and consist of:
Squama Manis: 15-19 part Carapax Trionycis: 22-26 part Bombyx Batryticatus: 11-15 part
Scorpio: 5-8 part Olibanum: 16-20 part Myrrha: 16-21 part
The Radix Angelicae Dahuricae: 5-8 part Radix Notoginseng: 4-8 part Hippocampus: 2-4 part
Scolopendra: 1.2-2.8 part eupolyphaga: 5-8 part Blatta seu periplaneta: 3-6 part
Rhizoma Picrorhizae: 13-18 part Flos Lonicerae: 30-45 part Fructus Forsythiae: 30-45 part
Radix Et Rhizoma Rhei: 7-9 part Herba Lysionoti Pauciflori: 16-19 part Carapax Eriocheir sinensis: 8-10 part
Cynanchum Komarrivii AI Iijiniski: 23-30 part Fructus Psoraleae: 16-19 part.
The described raw materials of effective components of wherein making consists of:
Squama Manis: 18 parts of Carapax Trionycis: 24 portions of Bombyx Batryticatus: 13.5 parts
Scorpio: 6 parts of Olibanums: 18 parts of Myrrhas: 18 parts
The Radix Angelicae Dahuricae: 6 portions of Radix Notoginseng: 6 portions of Hippocampus: 3 parts
Scolopendra: 2 parts of eupolyphaga: 6 portions of Blatta seu periplanetaes: 4.5 parts
Rhizoma Picrorhizae: 15 portions of Flos Loniceraes: 37.5 parts of Fructus Forsythiaes: 37.5 parts
Radix Et Rhizoma Rhei: 9 parts of Herba Lysionoti Paucifloris: 18 parts of Carapax Eriocheir sinensis: 9 parts
Cynanchum Komarrivii AI Iijiniski: 27 parts of Fructus Psoraleaes: 18 parts.
The invention has the beneficial effects as follows:
1. do not perform the operation, be not in hospital, short treating period, expense is low and do not develop immunity to drugs and drug resistance.Particularly the patient of not healing for long-term employing chemotherapy has Drug resistance and drug resistance though body is interior, and it is also very good to take therapeutic effect of the present invention.Clinical total obvious effective rate reaches 100%, and cure rate reaches more than 95%.
2. short treating period, good effect, 20 days per courses of treatment, general patient 1-3 gets final product rehabilitation a course of treatment.
3. the present invention is not decrease liver than the outstanding advantage of chemicals, have protect the liver, the nourishing the liver effect.
The specific embodiment
Below in conjunction with embodiment the present invention is described in further detail:
The invention provides a kind of medicine for the treatment of bone and joint tuberculosis, wherein make raw materials of effective components and consist of:
Squama Manis: 15-19 part Carapax Trionycis: 22-26 part Bombyx Batryticatus: 11-15 part
Scorpio: 5-8 part Olibanum: 16-20 part Myrrha: 16-21 part
The Radix Angelicae Dahuricae: 5-8 part Radix Notoginseng: 4-8 part Hippocampus: 2-4 part
Scolopendra: 1.2-2.8 part eupolyphaga: 5-8 part Blatta seu periplaneta: 3-6 part
Rhizoma Picrorhizae: 13-18 part Flos Lonicerae: 30-45 part Fructus Forsythiae: 30-45 part
Radix Et Rhizoma Rhei: 7-9 part Herba Lysionoti Pauciflori: 16-19 part Carapax Eriocheir sinensis: 8-10 part
Cynanchum Komarrivii AI Iijiniski: 23-30 part Fructus Psoraleae: 16-19 part.
Bone and joint tuberculosis are the pathological changes that tubercule bacillus intrusion human body bone or intraarticular cause, medicine unique distinction of the present invention is: a side takes into account and disappears, holds in the palm, mends three big-and-middle treatment therapies then, again to disappear, to hold in the palm, it is Kidney-Yin to protect Gu with heat-clearing and toxic substances removing, invigorating kidney, promoting blood circulation develops simultaneously again, and treating the poisonous disease with poisonous drugs is regulated patient's integrated environment, improves total quality, reach disease-resistant, the purpose of curing the disease.According to mentioned above principle, the effect in the medicine of the present invention is:
1). drug synergisms such as Squama Manis, Olibanum, Myrrha, Flos Lonicerae, Blatta seu periplaneta, Herba Lysionoti Pauciflori, Radix Notoginseng, Carapax Eriocheir sinensis are blood circulation promoting and blood stasis dispelling, again inducing menstruation to relieve menalgia.
2). Flos Lonicerae, Fructus Forsythiae, Rhizoma Picrorhizae are that heat-clearing and toxic substances removing moves back heat of wetting again.
3). Hippocampus, Radix Notoginseng, Fructus Psoraleae, Carapax Trionycis kidney invigorating and YANG supporting, nourishing YIN for suppressing the hyperactive YANG, resisting fatigue.
4). according to modern pharmacological research: Cynanchum Komarrivii AI Iijiniski, Blatta seu periplaneta, Fructus Psoraleae, Carapax Trionycis, Scorpio, Bombyx Batryticatus, Scolopendra, Flos Lonicerae, Radix Notoginseng, Hippocampus etc. all have the effect that improves immune function of human body.
5). Olibanum, Myrrha, Radix Notoginseng, Bombyx Batryticatus, Scorpio, Scolopendra, Herba Lysionoti Pauciflori, Cynanchum Komarrivii AI Iijiniski, the Radix Angelicae Dahuricae, Rhizoma Picrorhizae, Fructus Psoraleae synergism, promptly antibacterial, antibiotic, antifungal again.
6). Squama Manis, the Fructus Psoraleae human leukocytes that can raise increases resistance against diseases.
7). Flos Lonicerae, Fructus Forsythiae are heat clearing away antiinflammatory antiendotoxin again.
8). Carapax Trionycis, Flos Lonicerae, Fructus Forsythiae, Radix Notoginseng, Rhizoma Picrorhizae are detoxicating and resolving stagnation of pathogens, antiinflammatory, protect the liver again, liver protection effect.
The present invention treats the medicine of bone and joint tuberculosis, wherein makes raw materials of effective components and consists of:
Squama Manis: 15 parts of Carapax Trionycis: 22 portions of Bombyx Batryticatus: 11 parts
Scorpio: 5 parts of Olibanums: 16 parts of Myrrhas: 16 parts
The Radix Angelicae Dahuricae: 5 portions of Radix Notoginseng: 4 portions of Hippocampus: 2 parts
Scolopendra: 1.2 parts of eupolyphaga: 5 portions of Blatta seu periplanetaes: 3 parts
Rhizoma Picrorhizae: 13 portions of Flos Loniceraes: 30 parts of Fructus Forsythiaes: 30 parts
Radix Et Rhizoma Rhei: 7 parts of Herba Lysionoti Paucifloris: 16 parts of Carapax Eriocheir sinensis: 8 parts
Cynanchum Komarrivii AI Iijiniski: 23 parts of Fructus Psoraleaes: 16 parts.
The present invention treats the medicine of bone and joint tuberculosis, wherein makes raw materials of effective components and consists of:
Squama Manis: 18 parts of Carapax Trionycis: 24 portions of Bombyx Batryticatus: 13.5 parts
Scorpio: 6 parts of Olibanums: 18 parts of Myrrhas: 18 parts
The Radix Angelicae Dahuricae: 6 portions of Radix Notoginseng: 6 portions of Hippocampus: 3 parts
Scolopendra: 2 parts of eupolyphaga: 6 portions of Blatta seu periplanetaes: 4.5 parts
Rhizoma Picrorhizae: 15 portions of Flos Loniceraes: 37.5 parts of Fructus Forsythiaes: 37.5 parts
Radix Et Rhizoma Rhei: 9 parts of Herba Lysionoti Paucifloris: 18 parts of Carapax Eriocheir sinensis: 9 parts
Cynanchum Komarrivii AI Iijiniski: 27 parts of Fructus Psoraleaes: 18 parts.
The present invention treats the medicine of bone and joint tuberculosis, wherein makes raw materials of effective components and consists of:
Squama Manis: 19 parts of Carapax Trionycis: 26 portions of Bombyx Batryticatus: 15 parts
Scorpio: 8 parts of Olibanums: 20 parts of Myrrhas: 21 parts
The Radix Angelicae Dahuricae: 8 portions of Radix Notoginseng: 8 portions of Hippocampus: 4 parts
Scolopendra: 2.8 parts of eupolyphaga: 8 portions of Blatta seu periplanetaes: 6 parts
Rhizoma Picrorhizae: 18 portions of Flos Loniceraes: 45 parts of Fructus Forsythiaes: 45 parts
Radix Et Rhizoma Rhei: 9 parts of Herba Lysionoti Paucifloris: 19 parts of Carapax Eriocheir sinensis: 10 parts
Cynanchum Komarrivii AI Iijiniski: 30 parts of Fructus Psoraleaes: 19 parts.
The preparation that the present invention is treated bone and tuberculosis of joint medicine is described as follows below:
1). medicine of the present invention is divided into four groups:
First group: Squama Manis, Carapax Trionycis, Hippocampus, Radix Notoginseng, Carapax Eriocheir sinensis
Second group: Olibanum, Myrrha, Fructus Psoraleae, Rhizoma Picrorhizae
The 3rd group: Herba Lysionoti Pauciflori, Cynanchum Komarrivii AI Iijiniski, Blatta seu periplaneta, Scolopendra, Bombyx Batryticatus, Scorpio, eupolyphaga
The 4th group: Flos Lonicerae, Fructus Forsythiae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei
Following 9 kinds of medicines in above-mentioned four groups of medicines are used together with other drug after concocting by following method again:
1. Squama Manis is put into iron pan simultaneously with fine earth and is made popular, Squama Manis first sheet is sent out be split into pearl, make popular again with rice vinegar broken three times standby.
2. Carapax Trionycis is with being coated with white beeswax on the roasting heat of charcoal fire, roastingly again oozes only to wax, bakes repaste again, and is standby after totally five times.
3. Hippocampus is coated butter with Linesless charcoal baking heat, roasting again repaste totally five times.
4. Carapax Eriocheir sinensis is put into can sealing and is put charcoal fire and burn 15 minutes (can not be burnt red), cools from fire, and the cooling taking-up is standby.
5. Olibanum, Myrrha are fried several times with new watt respectively, are poured on while hot on the jute paper, are the standard of having fried to lose oil stain on the paper, can be standby.
6. the Fructus Psoraleae low baking temperature fry boil in water for a while, then dress with soy, vinegar, etc. when explosion is arranged behind the yellow wine standby.
7. Blatta seu periplaneta is scalded with boiled water and extremely dries in the shade, and cleans with yellow wine simultaneously, stirs to take out after 20 minutes to boil in a covered pot over a slow fire slightly with brine sparge with Pulvis concha Mactrae slow fire to get final product.
8. Scolopendra does not decaptitate sufficient in little roasting the getting final product of charcoal fire.
2). boil medicine or with the electric heating boiling machine method therefor of boiling medicine with traditional earth pot:
1. above-mentioned 4 groups of medicines are packed with gauze bag respectively.First group, second group was steeped 20 minutes with 4500 milliliters of yellow wine and equivalent water logging.
2. with 20 minutes at a simmer of first group of medicine, put into second group again and fried in shallow oil 15 minutes, put into the 3rd group again and fry in shallow oil and put into the 4th group after 15 minutes and fry in shallow oil and emitted medicinal liquid in 10 minutes.
3. be blended into each 1500 milliliters in yellow wine, water more simultaneously, first group to the 4th group medicine while slow fire was fried in shallow oil 25 minutes again, emit medicinal liquid, squeeze clean medicinal residues inner liquid medicine.
4. with above-mentioned two times medicine soup unification place cryoconcentration to 6000 milliliter.
5. use the packing of medicinal liquid racking machine, 100 milliliters every bag, totally 60 bags, cold preservation is standby.According to 200 routine clinical treatment observations:
1). spinal tuberculosis: 156 examples, no hospitalization, the range of age 12-68 year.Wherein male 68 people, women 88 people, wherein thoracic vertebra 61 examples, lumbar vertebra 95 examples, wherein pathologic paraplegia 66 people, cold abscess form 72 people.
Therapeutic Method: the medicinal liquid of endo-medicine, takes at twice 100 milliliters of every days.3/5 of 12-16 year clothes adult dose i.e. 60 milliliters of every days, takes at twice.Old person takes the circumstances into consideration decrement.
Treatment time: 20 days is a course of treatment, according to state of an illness weight, is generally 2-4 the course of treatment, the longest 6 courses of treatment.
Therapeutic outcome: wherein the state of an illness is longer, forms pathologic paraplegia, and concurrent cold abscess person has 138 people.With in the Drug therapy process of the present invention, the cold abscess bag pus person evacuation of pus of puncturing is arranged, the person gets rid of sequestrum the sequestrum.All 2-3 the tuberculosis sign alleviations course of treatment, pain relief, abscess is dwindled pus and is reduced, and part paralytic patient lower limb are regained consciousness; 12 example energy light activities are arranged, continue medication and all recover normal 2--4 the course of treatment.Have the 2 routine courses of disease longer, tuberculosis of spine is Spinal Cord behind the doctor trained in Western medicine debridement surgical once, with after the Drug therapy of the present invention, do not recover lower limb function, but the tuberculosis sign is eliminated all.3 examples are not adhered to treatment in addition, and back feelings are not quite clear.
Conclusion: 156 examples are produce effects 100% all, except that 3 examples are not adhered to treatment and 2 example operation sequela, and clinical whole healings.
2). coxodynia: 13 examples, no hospitalization, age 12-35 year, male 9 examples, women 4 examples
Therapeutic Method: the medicinal liquid of endo-medicine, takes at twice 100 milliliters of every days.3/5 of 12-16 year clothes adult dose i.e. 60 milliliters of every days, takes at twice.
Treatment time: 20 days is a course of treatment, according to state of an illness weight, is generally 2-4 the course of treatment, the longest 6 courses of treatment.
Therapeutic outcome: 1-3 course of treatment is all eliminated the tuberculosis signs, and the serious femur head necrosis debridement treatment of performing the operation in addition because of bone destruction causes of 1 example is arranged.All the other continue 2-4 course of treatment of medications, all recover normally.
Conclusion: except that 1 example is not adhered to treatment, clinical whole healings, cure rate 100%.
3). tuberculosis of sternum: 5 examples, no hospitalization, male 4 examples, women 1 example, year bell 19-46 year, cold abscess forms 3 examples.
Therapeutic Method: the medicinal liquid of endo-medicine, takes at twice 100 milliliters of every days.
Treatment time: 20 days is a course of treatment, according to state of an illness weight, is generally 2-4 the course of treatment, the longest 6 courses of treatment.
Therapeutic outcome: 3 routine abscess form, and composition of medicine for oral administration is three courses of treatment respectively, remission.2 examples are slightly taken medicine 2 courses of treatment of liquid, all eliminate symptom, and above-mentioned 5 examples all continue to take 2 courses of treatment, consolidate curative effect.
Conclusion: all cure.
4). tuberculosis of ankle joint: 14 examples, no hospitalization.Man's 5 examples, women 9 examples, age 28-52 year.
Therapeutic Method: the medicinal liquid of endo-medicine, takes at twice 100 milliliters of every days.
Treatment time: 20 days is a course of treatment, according to state of an illness weight, is generally 2-4 the course of treatment, the longest 6 courses of treatment.
Therapeutic outcome: take 2 the course of treatment equal relief of symptoms and pain, 1 example is arranged because of festering, sequestrum forms and also forms sinus tract, after adhere to taking medicine, discharge sequestrum, 6 recoveries from illness courses of treatment, fully recover surplus equal 5 courses of treatment.
Conclusion: all cure.
5). tuberculosis of wrist joint: 12 examples, no hospitalization, age 22-38 year, male 14 examples, women 8 examples.
Therapeutic Method: the medicinal liquid of endo-medicine, takes at twice 100 milliliters of every days.
Treatment time: 20 days is a course of treatment, according to state of an illness weight, is generally 2-4 the course of treatment, the longest 6 courses of treatment.
Therapeutic outcome: 2 the course of treatment whole relief of symptoms, continue to take 2 courses of treatment and all fully recover, 1 example is because of the discharge sequestrum that festers, after heal voluntarily, but function of joint is stiff.
Conclusion: all cure.
The treatment statistics of above-mentioned 200 routine bones and joint tuberculosis sees Table one
Table one
| The sick kind | The example number | The basic healing | The produce effects number | Cure rate % | Obvious effective rate % | ||
| The example number | Account for routine number ratio % | The example number | Account for routine number ratio % | ||||
| Spinal tuberculosis | 156 | 151 | 96.8％ | 156 | 100％ | 96.8％ | 100％ |
| Coxodynia | 13 | 12 | 92.3％ | 13 | 100％ | 92.3％ | 100％ |
| Tuberculosis of sternum | 5 | 5 | 100％ | 5 | 100％ | 100％ | 100％ |
| Tuberculosis of ankle joint | 14 | 14 | 100％ | 14 | 100％ | 100％ | 100％ |
| Tuberculosis of wrist joint | 12 | 12 | 100％ | 12 | 100％ | 100％ | 100％ |
Claims (2)
1. medicine for the treatment of bone and joint tuberculosis is characterized in that wherein making raw materials of effective components consists of:
Squama Manis: 15-19 part Carapax Trionycis: 22-26 part Bombyx Batryticatus: 11-15 part
Scorpio: 5-8 part Olibanum: 16-20 part Myrrha: 16-21 part
The Radix Angelicae Dahuricae: 5-8 part Radix Notoginseng: 4-8 part Hippocampus: 2-4 part
Scolopendra: 1.2-2.8 part eupolyphaga: 5-8 part Blatta seu periplaneta: 3-6 part
Rhizoma Picrorhizae: 13-18 part Flos Lonicerae: 30-45 part Fructus Forsythiae: 30-45 part
Radix Et Rhizoma Rhei: 7-9 part Herba Lysionoti Pauciflori: 16-19 part Carapax Eriocheir sinensis: 8-10 part
Cynanchum Komarrivii AI Iijiniski: 23-30 part Fructus Psoraleae: 16-19 part.
2. according to the medicine described in the claim 1, it is characterized in that wherein making raw materials of effective components consists of:
Squama Manis: 18 parts of Carapax Trionycis: 24 portions of Bombyx Batryticatus: 13.5 parts
Scorpio: 6 parts of Olibanums: 18 parts of Myrrhas: 18 parts
The Radix Angelicae Dahuricae: 6 portions of Radix Notoginseng: 6 portions of Hippocampus: 3 parts
Scolopendra: 2 parts of eupolyphaga: 6 portions of Blatta seu periplanetaes: 4.5 parts
Rhizoma Picrorhizae: 15 portions of Flos Loniceraes: 37.5 parts of Fructus Forsythiaes: 37.5 parts
Radix Et Rhizoma Rhei: 9 parts of Herba Lysionoti Paucifloris: 18 parts of Carapax Eriocheir sinensis: 9 parts
Cynanchum Komarrivii AI Iijiniski: 27 parts of Fructus Psoraleaes: 18 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410072295XA CN1261126C (en) | 2004-09-30 | 2004-09-30 | Medicine for treating bone and joint tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410072295XA CN1261126C (en) | 2004-09-30 | 2004-09-30 | Medicine for treating bone and joint tuberculosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1615999A CN1615999A (en) | 2005-05-18 |
| CN1261126C true CN1261126C (en) | 2006-06-28 |
Family
ID=34765195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200410072295XA Expired - Fee Related CN1261126C (en) | 2004-09-30 | 2004-09-30 | Medicine for treating bone and joint tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1261126C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083382A (en) * | 2013-01-05 | 2013-05-08 | 王广新 | Radix angelicae skin repairing pain relieving powder |
| CN107669770A (en) * | 2017-11-09 | 2018-02-09 | 任杰 | A kind of Chinese medicine for treating tuberculous osteoarthropathy |
-
2004
- 2004-09-30 CN CNB200410072295XA patent/CN1261126C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1615999A (en) | 2005-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1327807A (en) | Chinese medicine for treating neoplasm | |
| CN101361872A (en) | Traditional Chinese medicine for quickly treating bone fracture and postoperative nonunion and delayed healing | |
| CN1218729C (en) | Xuerongguyugao ointment for healing fracture and its prepn | |
| CN1876121A (en) | A medicinal wine capable of treating multiple diseases | |
| CN1261126C (en) | Medicine for treating bone and joint tuberculosis | |
| CN1286489C (en) | Scarless burn and scald treatment liquid and its preparation method | |
| CN103550698B (en) | Traditional Chinese medicine composition for treating acute cholecystitis | |
| CN1907394A (en) | Medicine for treating diabetes foot | |
| CN1290548C (en) | Traditional Chinese medicine for curing bone fracture and rheumatic diseases | |
| CN1181868C (en) | Chinese medicine prepn for treating obliterans thromboangitis | |
| CN100562326C (en) | A kind of Chinese medicine for outer use for the treatment of burn and preparation method thereof | |
| CN1293896C (en) | Medication for treating primary disease of purpura haemorhagica and preparation method | |
| CN1422662A (en) | Medicine for treating bone and joint tuberculosis | |
| CN1256102C (en) | Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation | |
| CN1055862C (en) | Chinese medicine preparation for curing osteonecrosis | |
| CN1060954C (en) | External use Chinese drug powder and its preparing method and medicinal pad | |
| CN1263498C (en) | Medicine for treating arthraligia caused by wind, cold and wetness evils and with beauty function and its preparing method | |
| CN1840152A (en) | Health-caring capsule for middle- and old- aged man and preparation method thereof | |
| CN1108166C (en) | Inflammation-relieving antalgic medicine and its preparing process | |
| CN104013880B (en) | It is a kind of to treat Chinese medicine composition of peritonitis and preparation method thereof | |
| CN1304027C (en) | Bone nourishing and rheumatic treating pills and their preparation | |
| CN1742770A (en) | Chinese medicine for treating fractures and processing technology thereof | |
| CN1313117C (en) | Chinese medicine external applied powder for bone damage | |
| CN1733074A (en) | Externally applied medicine for treating dermatosis | |
| CN105168978B (en) | Expelling wind and clearing away cold, relaxing tendons and activating collaterals, the Chinese medicine composition of dissipating blood stasis and reducing the stagnation treatment muscles and bones arthralgia and its medicine bolus for recuperating and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Ma Junfang Document name: Notification of registration procedures and notice of patent for invention |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |